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Value of the data
 The data can be useful for other researchers investigating signaling pathways associated with
CaMKII and AT1 receptor activation under setting of ischemia/reperfusion in the heart.
 These data also provide signiﬁcant contribution in understanding of pharmacological properties of
AT1 receptor inhibitors, drugs used in patients at high cardiovascular risk.1. Data
In ischemic/reperfused (IR) group treated with CaMKII inhibitor, but not with AT1 receptor inhi-
bitor, Bcl-2/Bax ratio was signiﬁcantly increased (Fig. 1) and the expression of caspase-3 and 89 kDa
apoptotic fragment of PARP1 was changed by neither CaMKII inhibition nor angiotensin AT1 receptor
inhibition (Fig. 2). 40 kDa necrotic fragment of PARP1 was upregulated in the IR group and no
intervention was able to normalize these levels (Fig. 3). In the double-treated IR hearts, the levels of
individual apoptotic and necrotic did not differ from those observed in either of mono-treated IR;
however, the p40PARP1/total PARP1 ratio was increased when compared to the IR group treated
with CaMKII inhibitor alone.2. Experimental design, materials and methods
Samples from the untreated and losartan and/or KN-93-treated hearts subjected to ischemia/
reperfusion injury were used to examine protein expression by immunoblotting.
Proteins were separated using the SDS-PAGE and transferred to PVDF membrane (EMD Millipore,
USA). The primary antibodies used were Bcl-2 (Sigma-Aldrich, USA), Bax (Cell Signaling, USA), PARP1
(Cell Signaling, USA), Caspase-3 (csp-3) p17 (Santa Cruz Biotechnology, USA) and β-actin (Sigma-
Aldrich, USA). A HRP-conjugated donkey anti-rabbit antibody (GE Healthcare Life Sciences, UK) was
Fig. 1. Expression of Bcl-2 and Bax. (a) Representative western blots (b) Bcl-2 and (c) Bax expression (d) Bcl-2/Bax ratio. The
values are expressed as the means7S.E.M. (n¼5–7 hearts per group). nPo0.05 vs. IR group.
Fig. 2. Expression of cleaved caspase-3. (a) Representative blots (b) content of cleaved caspase-3. The values are expressed as
the means7S.E.M. (n¼5–7 hearts per group).
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Fig. 3. Expression of total and cleavage fragments of PARP1. (a) Representative blots, (b) expression of total protein, (c) content
of apoptotic PARP1 p89 fragment, (d) apoptotic p89 fragment to total PARP1 ratio, (e) necrotic PARP1 p40 fragment and
(f) ratio of necrotic PARP1 fragment to total PARP1. The values are expressed as the means7S.E.M. (n¼5–7 hearts per group).
nPo0.05 vs. C; #Po0.05 vs. LOS group; &Po0.05 vs. IRþKN.
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niscence (Luminata, EMD Millipore, USA) and the blots were acquired using the MyECL Imager
(Thermo Scientiﬁc, USA).
Data are expressed as the means7S.E.M. Differences between variables with normal distribution
were statistically analyzed by ANOVAwith Newman–Keuls post-hoc test. Differences were considered
as signiﬁcant at Pr0.05.
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